NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011511 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Qiao Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Insti…. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesviridae Infections, Interferon Type I. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the grants from the national key R&D program of China, national natural sciences foundation of china, national natuial sciences foundation of China.
Abstract (Originalsprache)
The innate immune system is the first line of the host’s defense, and studying the mechanisms of the negative regulation of interferon (IFN) signaling is important for maintaining the balance of innate immune responses. Here, we found that the host GTP-binding protein 4 (NOG1) is a negative regulator of innate immune responses. Overexpression of NOG1 inhibited viral RNA- and DNA-mediated signaling pathways, and NOG1 deficiency promoted the antiviral innate immune response, resulting in the ability of NOG1 to promote viral replication. Vesicular stomatitis virus (VSV) and herpes simplex virus type 1 (HSV-1) infection induced a higher level of IFN-β protein in NOG1 deficient mice. Meanwhile, NOG1-deficient mice were more resistant to VSV and HSV-1 infection. NOG1 inhibited type I IFN production by targeting IRF3. NOG1 was also found to interact with phosphorylated IFN regulatory factor 3 (IRF3) to impair its DNA binding activity, thereby downregulating the transcription of IFN-β and downstream IFN-stimulated genes (ISGs). The GTP binding domain of NOG1 is responsible for this process. In conclusion, our study reveals an underlying mechanism of how NOG1 negatively regulates IFN-β by targeting IRF3, which uncovers a novel role of NOG1 in host innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
ORCID-Profile: Huisheng Liu
Förderung
- the grants from the national key R&D program of China
- national natural sciences foundation of china
- national natuial sciences foundation of China
- the key technologies R&D program of Gansu province
- the open competition program of top ten critical priorities of agricultural science and technology innovation for the 14th five-year plan of Guangdong province
- the project of national center of technology innovation for pigs
- the earmarked fund
Zitieren
APA
Xue, Q., Zhu, Z., Xue, Z., Yang, F., Cao, W., Liu, X., Liu, H., & Zheng, H. (2023). NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011511
Vancouver
Xue Q, Zhu Z, Xue Z, Yang F, Cao W, Liu X, et al. NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011511
BibTeX
@article{Xue2023,
author = {Xue, Qiao and Zhu, Zixiang and Xue, Zhaoning and Yang, Fan and Cao, Weijun and Liu, Xiangtao and Liu, Huisheng and Zheng, Haixue},
title = {NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011511}
}
EUVIMED